JG
VRTX icon

Jain Global’s Vertex Pharmaceuticals VRTX Stock Holding History

Jain Global’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73M Buy
9,529
+4,852
+104% +$2.15M 0.02% 583
2026
Q1 		$2.09M Sell
4,677
-20,301
-81% -$9.47M 0.01% 673
2025
Q4 		$11.3M Buy
+24,978
New +$10.8M 0.05% 309

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jain Global's VRTX Position: Q2 2026 in Review

Jain Global increased its Vertex Pharmaceuticals (VRTX) stake by 104% in Q2 2026, buying an estimated $2.15M and bringing the position to 9,529 shares worth $4.73M. The position accounts for 0.02% of the portfolio, ranked #583.

Jain Global first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.3M in Q4 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Jain Global held 9,529 shares of Vertex Pharmaceuticals worth $4.73M as of Q2 2026.
  • Jain Global bought 4,852 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.15M.
  • Vertex Pharmaceuticals made up 0.02% of Jain Global's portfolio in Q2 2026, its #583 holding.
  • Jain Global first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Jain Global's Vertex Pharmaceuticals position peaked at $11.3M in Q4 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.